Min Ou
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Tuberculosis Research and Epidemiology
- Neurology top 10%
- Long-Term Effects of COVID-19
Papers in
-
- Tuberculosis Research and Epidemiology 8
-
- Pharmacological Effects of Natural Compounds 4
- Co-authors
- Guoliang Zhang (13 shared papers)Zhaoqin Wang (6 shared papers)Guohui Xiao (5 shared papers)Lei Liu (4 shared papers)Xing He (5 shared papers)Jing Bi (5 shared papers)Hong Gao (1 shared paper)Rongqing Yang (1 shared paper)
- Journals
- The Journal of Infectious Diseases (3 papers)Journal of Separation Science (3 papers)BMC Microbiology (2 papers)Frontiers in Pharmacology (1 paper)Heliyon (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Min Ou
33 papers receiving 691 citations
Min Ou's Hit Papers
Peers
Comparison fields: 5 of 80
- Infectious Diseases 423
- Neurology 148
- Complementary and alternative medicine 27
- Obstetrics and Gynecology 23
- Biological Psychiatry 6
Countries citing papers authored by Min Ou
This map shows the geographic impact of Min Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Ou more than expected).
Fields of papers citing papers by Min Ou
This network shows the impact of papers produced by Min Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Ou. The network helps show where Min Ou may publish in the future.
Co-authors
The 25 scholars most cited alongside Min Ou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension Hit paper breakdown → | 2020 | 481 |
| 2 | 2021 | 24 | |
| 3 | 2019 | 21 | |
| 4 | 2021 | 20 | |
| 5 | 2023 | 18 | |
| 6 | 2008 | 15 | |
| 7 | 2022 | 15 | |
| 8 | 2019 | 11 | |
| 9 | 2023 | 9 | |
| 10 | 2022 | 9 | |
| 11 | 2022 | 9 | |
| 12 | 2009 | 8 | |
| 13 | 2022 | 8 | |
| 14 | 2018 | 8 | |
| 15 | 2025 | 7 | |
| 16 | 2022 | 5 | |
| 17 | 2009 | 5 | |
| 18 | 2009 | 4 | |
| 19 | A Brief Review on the Study of Seeds of Brassica Alba | 2001 | 3 |
| 20 | 2020 | 3 |
About Min Ou
Min Ou is a scholar working on Infectious Diseases, Pharmacology, Epidemiology, Complementary and alternative medicine and Virology, having authored 33 papers that have together received 706 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (8 papers), Plant Physiology and Cultivation Studies (4 papers), Pharmacological Effects of Natural Compounds (4 papers), Autophagy in Disease and Therapy (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Postharvest Quality and Shelf Life Management (4 papers), Polysaccharides and Plant Cell Walls (3 papers) and Traditional Chinese Medicine Analysis (3 papers). The work is most often cited by research in Infectious Diseases (423 citations), Neurology (148 citations), Complementary and alternative medicine (27 citations), Obstetrics and Gynecology (23 citations) and Biological Psychiatry (6 citations). Min Ou has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Guoliang Zhang, Zhaoqin Wang, Guohui Xiao, Lei Liu, Xing He, Jing Bi, Hong Gao, Rongqing Yang, Wencheng Di and Zigang Li. Their work appears in journals such as The Journal of Infectious Diseases, Journal of Separation Science, BMC Microbiology, Frontiers in Pharmacology and Heliyon.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.